Tesamorelin is one of those peptides that gets mentioned constantly in hormone optimization circles, but the practical details tend to get buried under hype.
How it works, what it does to your body, and whether it’s the right fit for your goals all deserve a clear explanation.
This guide covers the essentials without the fluff.
What Tesamorelin Actually Is
Tesamorelin is a synthetic analog of the growth hormone-releasing hormone (GHRH), a 44-amino acid peptide that is structurally and functionally similar to the natural 44-amino acid GHRH produced by the hypothalamus.
Tesamorelin, known by the brand name Egrifta, was approved by the FDA in 2010 as a treatment for visceral abdominal fat in patients with HIV-associated lipodystrophy.
Lipodystrophy causes redistribution of fat in abnormal patterns, with considerable deposits in the trunk and abdominal regions.
The fact that Tesamorelin has been approved for a very narrow indication goes a long way to determining how it is prescribed, studied and discussed in the clinical setting.
How the Mechanism Works
Your body already runs a growth hormone feedback loop.
GHRH is secreted by the hypothalamus and acts as a key messenger at the anterior pituitary gland to stimulate secretion of human Growth Hormone (HGH).
This HGH is active in the blood for about 20-30 minutes, before being inactive for about 90 minutes, until the hypothalamus triggers another pulse of GHRH and another release of HGH from the pituitary gland. This HGH then travels through the blood to the liver, where it is converted into a second protein, IGF-1 or insulin-like growth factor 1.
Both HGH and IGF-1 are potent stimulators of fat metabolism and affect many aspects of growth and development including repair of body tissues, strengthening of bones, and improvement in body composition.
Tesamorelin plugs directly into this existing system.
This synthetic peptide is different from straight HGH in that it stimulates the pituitary to release naturally prepared growth hormone, as opposed to just pumping tons of growth hormone into the body like a synthetic HGH shot.
These growth hormones are released in a pulsatile fashion, which is how naturally occurring growth hormones are released in the body. This is why the side effect profile is generally considered to be milder than with direct administration of synthetic HGH for growth hormone therapy.
It is also important to note that Tesamorelin works only if the pituitary gland is functioning normally.
Individuals with severe or profound pituitary insufficiency, or individuals with marked age-related decline in populations of somatotroph cells, are less likely to have an adequate response to Tesamorelin.
Why People Use It Beyond the FDA Label
While Tesamorelin has only been approved for HIV-associated lipodystrophy, it is of interest to other patient populations including those on anti-aging/hormone optimization protocols as well as individuals looking to treat metabolic disease.
Several clinicians including those involved in anti-aging medicine, hormone replacement therapy and metabolic optimization have also investigated Tesamorelin for its potential in improving body composition and lipid profiles as well as other functions including possibly improving cognitive function.
- Visceral fat reduction: Tesamorelin has been shown in multiple clinical trials to decrease trunk fat as measured by CT scan. This is deep visceral fat (around organs) that is a risk factor for metabolic disease. Typically this type of fat is very difficult to lose with diet and exercise alone.
- Improved Body Composition: Individuals on Tesamorelin showed reduction in Waist Circumference and Improvement in Lean Body Mass to Fat Mass Ratio. Most importantly, significant portion of this improvement occurred without strict dietary controls.
- Cognitive function: There are only a few reports on the effect of Tesamorelin in older adults. Some improvement in Executive Functions (EF) and Verbal Memory has been reported. This is thought to be a result of Tesamorelin’s IGF-1 signal transduction in the brain.
- Effects on the lipid profile: In some patients, the drug led to a reduction in the triglyceride levels, most likely due to growth hormone’s effects on the hepatic lipid metabolism.
When prescribed by physicians as part of an anti-aging treatment protocol, the evidence-based peptide Tesamorelin is prescribed off-label in cases where FDA-approved uses for the compound have not been indicated.
Dosing and Administration
Initial recommended dosing as stated in the Egrifta prescribing information is 2 mg subcutaneously once daily.
Individuals generally use the abdomen to administer the injections, rotating the injection site to prevent scar tissue, bruising, or lipodystrophy at the injection point. Avoid injecting into the navel.
Tesamorelin is supplied as a lyophilized (powdered) form that must be reconstituted before subcutaneous injection. The diluent and storage rules differ by formulation, and getting this wrong matters:
Original Egrifta (1 mg/vial) and Egrifta SV (2 mg/vial): reconstituted with Sterile Water for Injection, USP — not bacteriostatic water. Per the FDA label, the reconstituted solution should be administered immediately, with any unused solution discarded. It should not be frozen or refrigerated for later use.
Egrifta WR (11.6 mg/vial), a newer, less frequently dosed formulation, uses Bacteriostatic Water for Injection, USP, as its diluent, and its reconstituted solution can be stored at room temperature (20-25°C) for up to 7 days before being discarded.
Compounded/research-grade tesamorelin (i.e., not the branded Egrifta products) is commonly reconstituted with bacteriostatic water and stored refrigerated for a longer window in practice, but this is a compounding-pharmacy convention, not something specified in an FDA label, and stability data for these preparations is limited. Always follow the specific compounding pharmacy’s instructions rather than assuming branded-label timelines apply.
Unreconstituted vials (any formulation) should be stored refrigerated at 2-8°C, protected from light, in the original box until use.
Timing matters to some degree. Administering the injection on an empty stomach — in the morning or before bedtime — helps maximize the growth hormone response, since high blood glucose and recent elevated insulin can blunt GH release. Avoiding food for roughly 2 hours before and 30-60 minutes after injection is a commonly recommended window to support this.
What to Expect in the First Few Weeks
Tesamorelin is not a fast-acting compound.
It is typically 7-14 days before an increase in IGF-1 levels can be measured. The length of time until actual changes in body composition can typically take up to 8-12 weeks and continue to improve until 26 weeks.
Reductions in fat mass around the abdominal region have been noted to commence approximately within 8-12 weeks with continued decrease up to 26 weeks in clinical trials.
People report improved sleep and sometimes an improvement in the look of their skin within a month or so, likely due to higher GH pulsing during slow-wave sleep.
Side effects in the first couple of weeks are typically mild.
For Tesamorelin typically, there are many mild effects reported by people. Most of them are listed at the start of this page but notably there are reports of effects such as pain in joints, more wetness in feet, injection site soreness/irritation (redness, swelling, itching etc).
Joint pain or fluid retention in the hands and/or feet can occur during the initial treatment period as the body adjusts to increased levels of growth hormone.
Individuals on the peptide, particularly those with pre-diabetes or type 2 diabetes, should monitor their fasting glucose and HbA1c values. Growth hormone has counter-regulatory effects on insulin.
Key Considerations Before Starting
Blood work is non-negotiable.
You want a complete blood test (including a comprehensive metabolic panel) and measurement of IGF-1, fasting insulin, glucose, and HbA1c before starting the compound.
Without having gotten baseline levels for your IGF-1, and your fasting insulin, glucose, HbA1c, and comprehensive metabolic panel values, you have no way to know whether the compound is having any positive effects.
It stops working when you stop using it.
These benefits are not long lasting as was shown in the pivotal trials discontinuation phases where subjects’ visceral fat reaccumulated after cessation of Tesamorelin.
And remember, unlike what many promise, the effects of the peptide last only as long as you use it to take it.
Source quality varies widely.
Additionally, Tesamorelin is typically manufactured by compounding pharmacies outside of the Egrifta brand name and thus can vary significantly in terms of purity, accurate peptide content, and proper sterilization.
Durable solutions for Peptide Therapy are offered by Clinics such as the Bowery Clinic and Compounder Pharmacies that specialize in peptide therapy who source from licensed compounding pharmacies and provide certificates of analysis and confirm that all of their peptide solutions are made and stored in accordance with USP 797/800 guidelines.
Research-grade peptides often do not meet even the minimal standards of quality online, which can lead to problems like contamination and poor dosing accuracy.
Who Should Probably Avoid It
Tesamorelin is contraindicated in a few clear scenarios.
Cancer (active): Tesamorelin can promote the proliferation of cancer cells. Growth hormone and IGF-1 can act to promote the growth of existing tumors.
Egrifta is contraindicated in pregnant women.
People with a past history of hypersensitivity to Tesamorelin (or to mannitol, an excipient used in some formulations of the drug) should also avoid the drug.
A person with disrupted hypothalamic-pituitary function from surgery, radiation, or a congenital defect will likely not get any benefit from Tesamorelin as their pituitary is not functioning normally.
The Bottom Line
Tesamorelin works by stimulating the body’s own production of Growth Hormone (GH) through a well characterized pathway. There is substantial clinical evidence that Tesamorelin works and is well tolerated by most individuals with minimal side effects when properly managed under the care of a qualified physician.
Work with a smart physician, monitor for side effects, take before and after blood work measurements, and be realistic about how long it will take to produce results and how much weight you will lose.
The evidence supports what Tesamorelin does.
However, your goals, current state of health, and degree of commitment to maximize effects will dictate the degree to which Tesamorelin can be of benefit for you.
Written by Lea Collins (lea@sapurex.com)
